Healthcare Media & Clinician Networks
Doceree vs Sermo
Structured technology and market comparison · 2026
Direct Feature Comparison
Doceree · vs · Sermo| Attribute | ||
|---|---|---|
| Market Cluster / Sector | Healthcare Media & Clinician Networks | Healthcare Media & Clinician Networks |
| Business Model / Role | AdTech Vendor · Publisher & Media Owner | Publisher & Media Owner · Data Provider / Broker |
| Platform Focus | Healthcare adtech platform for pharma, publishers and HCP targeting. | Verified clinician network monetised through research, insights and healthcare advertising. |
| Company Size | 201–500 employees | 201–500 employees |
| Headquarters | United States | United States |
| Year Founded | 2020 | 2000 |
| Dossier & Alternatives |
Analyze all overlapping signals and tech stacks for Doceree and Sermo
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Doceree and Sermo?
When comparing Doceree and Sermo, both platforms operate within the Native & Contextual Ads, Publisher & Media Owner, and Display Ads & Banner ecosystem. Doceree is positioned as Healthcare adtech platform for pharma, publishers and HCP targeting, whereas Sermo focuses on Verified clinician network monetised through research, insights and healthcare advertising. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Doceree and Sermo?
When evaluating Doceree and Sermo, enterprise buyers also consider other platforms in Native & Contextual Ads, Publisher & Media Owner, and Display Ads & Banner. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Doceree and Sermo compare?
Doceree is headquartered in United States (founded in 2020) with 201–500 employees. Sermo is based in United States (founded in 2000) with 201–500 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Doceree vs Sermo
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Doceree
Recent Signals
- ·DocereeProduct & Platform Launch
Real Time HCP Targeting: How Fast Should Pharma Act on Clinical Intent Signals?
Doceree's article argues that real-time HCP targeting should be measured by signal-to-exposure time, not just data freshness. It outlines four latency stages—signal detection, verified HCP identity, signal-to-activation, and activation-to-exposure—and recommends specific metrics for pharma teams. Doceree's Clinical Intent Signals combine EHR activity, prescribing behavior, and point-of-care context with verified provider identity for NPI-level targeting. Its Intent Powered HCP Suite activates these signals across point of care, programmatic, social, and CTV.
- Doceree defines real-time HCP targeting as the time between a clinical event and the first relevant HCP exposure, not merely signal processing time.
- The clinical signal path includes clinical activity → signal detection → HCP identification → audience activation → ad delivery, with potential latency at each stage.
- Doceree's Clinical Intent Signals use EHR activity, prescribing behavior, point-of-care context, and other decision-moment signals, combined with verified provider identity for NPI-level targeting.
- ·DocereeProduct & Platform Launch
Highlights of the Fierce Pharma Week 2026
On September 14, 2026, Doceree launched its Intent-Powered HCP Suite with a rooftop event and a 300-drone show over Philadelphia, followed by a three-day presence at Fierce Pharma Week 2026. The launch featured the new Daily Command decision layer and extended real-time clinical intent orchestration to CTV, social, and programmatic, alongside existing point-of-care and DOOH channels. During the week, Harshit Jain held a fireside chat with Maria Menounos on clinical intent, and Doceree hosted sessions on agentic AI and reaching all three moments of the prescription journey.
- On September 14, 2026, Doceree hosted a Rooftop Social at Assembly Rooftop Lounge at The Logan Hotel in Philadelphia and launched its Intent-Powered HCP Suite with a 300-drone show over the city.
- The drone show spelled 'Clinical Intent Signals' and 'Understand every intent. Improve every outcome.' above Philadelphia.
- The Intent-Powered HCP Suite extends real-time clinical intent orchestration to CTV, Social, and Programmatic, complementing existing Care Sequence, DOOH, and Point of Care channels.
Sermo
Recent Signals
No recent market signals documented for Sermo in the current tracking window.
Start with a company or market. Track what changes.
Create your Polaris7 workspace to explore extended company profiles, organize relevant players into Watchlists, and receive focused briefings when material changes occur.
Doceree vs. Sermo
Compare capabilities, ecosystem relationships, and recent signals side by side in Polaris7.
Company Comparisons
Compare capabilities, ecosystem relationships, and recent signals side by side in Polaris7.
